Bionano reports preliminary fourth quarter and full-year 2023 results

San diego, jan. 08, 2024 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today reported certain unaudited preliminary financial and commercial highlights for the fourth quarter and fiscal year ended december 31, 2023. the company's full results for the fourth quarter and the fiscal year ended december 31, 2023 are not yet available.
BNGO Ratings Summary
BNGO Quant Ranking